Zhuhai, Guangdong, China In 2010 was created Livzon Mabpharm, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The main department of described Corporate Investor is located in the Zhuhai.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Therapeutics, Life Science. Among the various public portfolio startups of the fund, we may underline Epirus Biopharmaceuticals Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2005.
The typical case for the fund is to invest in rounds with 8 participants. Despite the Livzon Mabpharm, startups are often financed by Montreux Equity Partners, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Mousse Partners, Montreux Equity Partners.
Related Funds
| Fund Name | Location |
| Center of Aging and Brain Health Innovation | Canada, Ontario, Toronto |
| Changjiang Zheshang Unity Holdings | - |
| ConvergInce Holdings | England, London, United Kingdom |
| FleetBoston Financial Group | Boston, Massachusetts, United States |
| GAUSS Japan | Japan, Kanagawa Prefecture, Kawasaki |
| Generation Ventures | Canada, Ontario, Toronto |
| Hard Money Collective | - |
| Hezhong Guquan Touzi | - |
| Kaplan Ventures | Florida, Miami, United States |
| Morrag Investments | - |
| Ningbo Huaqiang Ruizhe Investment Partnership | China, Ningbo, Zhejiang |
| Nobska Point Capital | Boston, Massachusetts, United States |
| Portal Capital | Beachwood, Ohio, United States |
| Ride Ventures | Mount Kisco, New York, United States |
| SLATE CAPITAL GROUP | Baltimore, Maryland, United States |
| Stichting DOEN | Amsterdam, Noord-Holland, The Netherlands |
| TerraLab Ventures | Hamada, Japan, Shimane Prefecture |
| TIE Toronto | Canada, Ontario, Toronto |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Epirus Biopharmaceuticals | $36M | 16 Apr 2014 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Epirus Biopharmaceuticals | $36M | 16 Apr 2014 | Boston, Massachusetts, United States |
